Silicon Valley startup accelerators on the hunt for health-tech talent

Published 21/08/2014, 00:04
Silicon Valley startup accelerators on the hunt for health-tech talent

By Christina Farr

SAN FRANCISCO (Reuters) - What do Dropbox, Stripe, Airbnb and Reddit have in common? These technology firms all received mentorship and money from Silicon Valley's so-called startup machine, Y Combinator.

Now, for the first time in its nine-year history, the accelerator programme is actively recruiting health-technology startups. To attract top talent in healthcare and biotech, Y Combinator recently tapped medical executive Elizabeth Iorns as a part-time partner.

Sam Altman, Y Combinator's president, told Reuters he expects to see a growing number of venture capitalists investing in early-stage biotech and digital health companies.

"When we move into a new area, the venture capitalists usually don't like it," he said. "It takes them a couple years to come around."

But increasingly, Silicon Valley is opening its checkbook to health startups. Digital health, a particularly trendy area that includes wearable technology and electronic health records, received $1.9 billion (1.14 billion pounds) in 2013, a 39 percent jump from the previous year, according to data collected by venture fund Rock Health.

Y Combinator's interest in health-tech echoes some of the largest technology firms - Google, Apple and Samsung. Similarly to these firms, Y Combinator is hoping to corner a sliver of the American healthcare market, which accounts for an estimated 20 percent of U.S. gross domestic product.

"It's the right time for us to try health care," Altman said, as the "cost and cycle time" have dramatically decreased in recent years.

About a dozen health startups showcased their products and services to a roomful of press and venture capitalists at Y Combinator's demo day. This marked the largest number of health-related startups in Y Combinator's history, Altman said. The companies that presented on Tuesday included The Immunity Project, which is developing an HIV vaccine, and Boston-based Gingko Bioworks, which is working on a project to treat antibiotic-resistant germs.

Other digital health funds, including Rock Health, say they hope Y Combinator's interest in the space will open the floodgates to new sources of funding.

Y Combinator offers funding and advice, in exchange for about 6 percent of each startup's equity. It was founded by Paul Graham, a notable programmer and venture capitalist.

(Reporting by Christina Farr; Editing by Leslie Adler)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.